Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 3,708 | 1,925 | 1,504 | 1,046 | 1,162 |
| Cost of Goods | 28 | N/A | N/A | N/A | N/A |
| Gross Profit | 3,680 | 1,925 | 1,504 | 1,046 | 1,162 |
| Operating Expenses | 13,560 | 5,445 | 4,326 | 2,269 | 2,914 |
| Operating Income | -9,852 | -3,520 | -2,823 | -1,222 | -1,752 |
| Interest Expense | 124 | 1,654 | 966 | 233 | 157 |
| Other Income | -2,211 | 30 | 8 | 17 | 44 |
| Pre-tax Income | -12,187 | -5,144 | -3,781 | -1,438 | -1,865 |
| Net Income Continuous | -12,187 | -5,144 | -3,781 | -1,438 | -1,865 |
| Minority Interests | -1,003 | -1 | N/A | N/A | N/A |
| Net Income | $-11,185 | $-5,143 | $-3,781 | $-1,438 | $-1,865 |
| EPS Basic Total Ops | -0.28 | -0.18 | -0.16 | -0.06 | -0.08 |
| EPS Basic Continuous Ops | -0.30 | -0.18 | -0.16 | -0.06 | -0.08 |
| EPS Diluted Total Ops | -0.28 | -0.18 | -0.16 | -0.06 | -0.08 |
| EPS Diluted Continuous Ops | -0.30 | -0.18 | -0.16 | -0.06 | -0.08 |
| EBITDA(a) | $-8,413 | $-2,917 | $-2,743 | $-1,412 | $-1,894 |